We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dover
DOV
$28.3B
| $116M | 0.29% |
1,070,578
+391,094
| +58% | +$41.9M |
|
77
Starbucks
SBUX
$121B
| $112M | 0.28% |
1,308,209
-42,400
| -3% | -$3.38M |
|
78
Advanced Micro Devices
AMD
$786B
| $108M | 0.27% |
1,321,700
-27,100
| -2% | -$2.01M |
|
79
ServiceNow
NOW
$121B
| $106M | 0.26% |
1,090,000
-7,000
| -0.6% | -$625K |
|
80
Lam Research
LRCX
$385B
| $105M | 0.26% |
3,174,700
-314,340
| -9% | -$10.8M |
|
81
Chevron
CVX
$371B
| $105M | 0.26% |
1,454,093
+350,700
| +32% | +$29.5M |
|
82
Willis Towers Watson
WTW
$31.4B
| $104M | 0.26% |
497,788
+48,300
| +11% | +$9.86M |
|
|
VISN
83
Vistance Networks Inc
VISN
$2.79B
| $104M | 0.26% |
11,511,045
-71,820
| -0.6% | -$676K |
|
84
Boeing
BA
$190B
| $103M | 0.26% |
620,319
+41,187
| +7% | +$7.02M |
|
|
IMMU
85
DELISTED
Immunomedics Inc
IMMU
| $102M | 0.26% |
+1,200,000
| New | +$60.7M |
|
86
Becton Dickinson
BDX
$47B
| $99.8M | 0.25% |
439,740
+89,800
| +26% | +$22.1M |
|
87
Sempra
SRE
$55.3B
| $98.9M | 0.25% |
1,671,600
+219,000
| +15% | +$13.5M |
|
88
Citigroup
C
$231B
| $98.1M | 0.25% |
2,274,786
-1,279,202
| -36% | -$63.7M |
|
89
S&P Global
SPGI
$121B
| $97.3M | 0.24% |
269,805
-39,756
| -13% | -$14M |
|
90
Intuit
INTU
$89.7B
| $95.7M | 0.24% |
293,400
-9,300
| -3% | -$2.91M |
|
91
Edison International
EIX
$26.3B
| $94.4M | 0.24% |
1,855,835
-258,649
| -12% | -$13.8M |
|
92
IBM
IBM
$222B
| $93.2M | 0.23% |
801,435
-21,338
| -3% | -$2.51M |
|
|
ALXN
93
DELISTED
Alexion Pharmaceuticals
ALXN
| $92.7M | 0.23% |
810,058
-158,000
| -16% | -$17M |
|
94
Mondelez International
MDLZ
$79.9B
| $91.9M | 0.23% |
1,598,797
+110,400
| +7% | +$6.15M |
|
95
Gentex
GNTX
$5.14B
| $91.8M | 0.23% |
3,564,083
-348,871
| -9% | -$9.27M |
|
|
NVMI
96
Nova
NVMI
$12.8B
| $90.9M | 0.23% |
1,743,017
-150,269
| -8% | -$7.7M |
|
97
Kimberly-Clark
KMB
$37.3B
| $89M | 0.22% |
603,034
+90,711
| +18% | +$13.6M |
|
98
Target
TGT
$67.1B
| $88.3M | 0.22% |
560,808
-18,200
| -3% | -$2.5M |
|
99
CVS Health
CVS
$126B
| $86M | 0.22% |
1,473,274
-35,500
| -2% | -$2.21M |
|
100
RTX Corp
RTX
$300B
| $85.9M | 0.22% |
1,492,634
-1,317,646
| -47% | -$80.2M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.